Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00090402 · ClinicalTrials.gov registry record · Phase 1
Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
A Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00090402 is a Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 39 participants.
The verdict
NCT00090402, a Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of fish oil and the antioxidant alpha lipoic acid on factors in the blood that are associated with the progression of Alzheimer's Disease (AD).
Interventions
- DIETARY_SUPPLEMENT Fish Oil
- DIETARY_SUPPLEMENT Lipoic Acid
- OTHER Fish Oil Placebo
- OTHER Lipoic Acid Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00090402
The ClinicalTrials.gov registry entry for NCT00090402 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Fish Oil is the first listed.
NCT00090402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00090402 about?
NCT00090402 is a clinical study titled "Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease". The purpose of this study is to determine the effect of fish oil and the antioxidant alpha lipoic acid on factors in the blood that are associated with the progression of Alzheimer's Disease (AD).
What is the current status of trial NCT00090402?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2004-04. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00090402?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT), Lipoic Acid (DIETARY_SUPPLEMENT), Fish Oil Placebo (OTHER), Lipoic Acid Placebo (OTHER).
Who is sponsoring clinical trial NCT00090402?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.